Earnings Beat: Healthcare Services Group, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Shareholders will be ecstatic, with their stake up 49% over the past week following Healthcare Services Group, Inc.'s (NASDAQ:HCSG) latest quarterly results. It looks like a credible result overall - although revenues of US$448m were what the analysts expected, Healthcare Services Group surprised by delivering a (statutory) profit of US$0.23 per share, an impressive 27% above what was forecast. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Taking into account the latest results, the most recent consensus for Healthcare Services Group from five analysts is for revenues of US$1.81b in 2025. If met, it would imply a credible 3.8% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to soar 47% to US$0.84. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$1.79b and earnings per share (EPS) of US$0.74 in 2025. There was no real change to the revenue estimates, but the analysts do seem more bullish on earnings, given the nice gain to earnings per share expectations following these results.

View our latest analysis for Healthcare Services Group

The analysts have been lifting their price targets on the back of the earnings upgrade, with the consensus price target rising 11% to US$15.00. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on Healthcare Services Group, with the most bullish analyst valuing it at US$17.00 and the most bearish at US$13.00 per share. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. One thing stands out from these estimates, which is that Healthcare Services Group is forecast to grow faster in the future than it has in the past, with revenues expected to display 5.1% annualised growth until the end of 2025. If achieved, this would be a much better result than the 0.8% annual decline over the past five years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 6.7% annually for the foreseeable future. Although Healthcare Services Group's revenues are expected to improve, it seems that the analysts are still bearish on the business, forecasting it to grow slower than the broader industry.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Healthcare Services Group's earnings potential next year. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Healthcare Services Group's revenue is expected to perform worse than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

With that in mind, we wouldn't be too quick to come to a conclusion on Healthcare Services Group. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Healthcare Services Group analysts - going out to 2027, and you can see them free on our platform here.

We also provide an overview of the Healthcare Services Group Board and CEO remuneration and length of tenure at the company, and whether insiders have been buying the stock, here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.